Although the underlying mechanism needs to be further explored, these findings provide support for the elevated levels of CETN2 and POFUT1 autoantibodies in precancerous lesions and their application in the clinical diagnosis of early ESCC. The gene discussed is POFUT1; the disease is esophageal squamous cell carcinoma.